David Pirman

1.5k total citations
18 papers, 749 citations indexed

About

David Pirman is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, David Pirman has authored 18 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Spectroscopy and 3 papers in Oncology. Recurrent topics in David Pirman's work include Metabolomics and Mass Spectrometry Studies (7 papers), Mass Spectrometry Techniques and Applications (5 papers) and Analytical Chemistry and Chromatography (3 papers). David Pirman is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (7 papers), Mass Spectrometry Techniques and Applications (5 papers) and Analytical Chemistry and Chromatography (3 papers). David Pirman collaborates with scholars based in United States, Netherlands and Canada. David Pirman's co-authors include Richard A. Yost, Ron M. A. Heeren, András Kiss, Gromoslaw A. Smolen, Christopher E. Mahoney, Giovanni Cianchetta, Stefan Größ, Thomas P. Roddy, Rohini Narayanaswamy and Janeta Popovici-Müller and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

David Pirman

17 papers receiving 743 citations

Peers

David Pirman

SPECT

ONCOL

IMMUN

Sankha S. Basu United States

Luojiao Huang China

Martin J. Voorbach United States

Peter F. Doubleday United States

Christian Guenat Switzerland

Ilaria Piazza Germany

Catharina Crone Germany

Leo E. Bonilla United States

Lambert Ngoka United States

Jon P. DeGnore United States

Sankha S. Basu United States

David Pirman

457 ×1.1

174 ×0.6

SPECT

100 ×0.7

48 ×0.5

ONCOL

100 ×1.4

IMMUN

Citations per year, relative to David Pirman David Pirman (= 1×) peers Sankha S. Basu

Countries citing papers authored by David Pirman

Since Specialization

Citations

This map shows the geographic impact of David Pirman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pirman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pirman more than expected).

Fields of papers citing papers by David Pirman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Pirman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pirman. The network helps show where David Pirman may publish in the future.

Co-authorship network of co-authors of David Pirman

This figure shows the co-authorship network connecting the top 25 collaborators of David Pirman. A scholar is included among the top collaborators of David Pirman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Pirman. David Pirman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bunin, Anna, Seong Lee, Simone M. Nicholson, et al.. (2024). Novel Bispecific Degrader BHV-1300 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models Including Nonhuman Primates (S43.004). Neurology. 102(7_supplement_1). 1 indexed citations

Vriens, Joris, Jean‐Christophe Vanherck, Arnaud Marchand, et al.. (2024). BHV-2100, a First-in-class TRPM3 Antagonist for the Treatment of Pain (S13.002). Neurology. 102(7_supplement_1).

Masud, Sanna N., Megha Chandrashekhar, Michael Aregger, et al.. (2022). Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux. Nature Chemical Biology. 18(12). 1370–1379. 7 indexed citations

Best, Sarah A., Patrick M. Gubser, Shalini Sethumadhavan, et al.. (2022). Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer. Cell Metabolism. 34(6). 874–887.e6. 115 indexed citations

Nagaraja, Raj, Andrew Olaharski, Rohini Narayanaswamy, et al.. (2020). Preclinical toxicology profile of squalene epoxidase inhibitors. Toxicology and Applied Pharmacology. 401. 115103–115103. 17 indexed citations

Padyana, Anil K., Stefan Größ, Lei Jin, et al.. (2019). Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase. Nature Communications. 10(1). 99 indexed citations

Pirman, David, et al.. (2019). Metabolic analysis reveals evidence for branched chain amino acid catabolism crosstalk and the potential for improved treatment of organic acidurias. Molecular Genetics and Metabolism. 128(1-2). 57–61. 13 indexed citations

Miller, Russell, Wenyun Lu, David Pirman, et al.. (2018). Targeting hepatic glutaminase activity to ameliorate hyperglycemia. Nature Medicine. 24(4). 518–524. 54 indexed citations

Wang, Xiaoping, Dongwei Zhang, Yohei Funakoshi, et al.. (2017). EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer. Oncotarget. 8(40). 67904–67917. 34 indexed citations

10.

Meissen, John K., David Pirman, Min Wan, et al.. (2016). Phenotyping hepatocellular metabolism using uniformly labeled carbon-13 molecular probes and LC-HRMS stable isotope tracing. Analytical Biochemistry. 508. 129–137. 6 indexed citations

11.

Allen, Eric L., Danielle Ulanet, David Pirman, et al.. (2016). Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH. Cell Reports. 17(3). 876–890. 53 indexed citations

12.

Pirman, David. (2015). Quantitative Profiling of Tissue Drug Distribution by MS Imaging. Bioanalysis. 7(20). 2649–2656. 10 indexed citations

13.

Pirman, David, Ekem T. Efuet, Yong Pan, et al.. (2013). Changes in Cancer Cell Metabolism Revealed by Direct Sample Analysis with MALDI Mass Spectrometry. PLoS ONE. 8(4). e61379–e61379. 30 indexed citations

14.

Pirman, David, et al.. (2012). Quantitative MALDI Tandem Mass Spectrometric Imaging of Cocaine from Brain Tissue with a Deuterated Internal Standard. Analytical Chemistry. 85(2). 1081–1089. 157 indexed citations

15.

Zhang, Dongwei, Gabriel N. Hortobágyi, David Pirman, et al.. (2012). Abstract 569: Targeting inflammatory pathways as an effective therapeutic approach to suppress tumorigenicity and prevent metastasis in inflammatory breast cancer. Cancer Research. 72(8_Supplement). 569–569. 1 indexed citations

16.

Pirman, David, András Kiss, Ron M. A. Heeren, & Richard A. Yost. (2012). Identifying Tissue-Specific Signal Variation in MALDI Mass Spectrometric Imaging by Use of an Internal Standard. Analytical Chemistry. 85(2). 1090–1096. 72 indexed citations

17.

Pirman, David & Richard A. Yost. (2011). Quantitative Tandem Mass Spectrometric Imaging of Endogenous Acetyl-l-carnitine from Piglet Brain Tissue Using an Internal Standard. Analytical Chemistry. 83(22). 8575–8581. 78 indexed citations

18.

Colahan, Patrick T., et al.. (2007). Plasma concentration and local anesthetic activity of procaine hydrochloride following subcutaneous administration to horses. American Journal of Veterinary Research. 68(5). 495–500. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact